Showing results (541-550 of 3,148) with videos related to
Sort By:
Pageof 315
Neuro-Oncology|February 5, 2019
Identification of genes functionally involved in the detrimental effects of mutant histone H3.3-K27M in Drosophila melanogasterJohannes Berlandi, Amel Chaouch, Nicolas De Jay, et al.Neuro-Oncology|February 5, 2019
A low percentage of metastases in deep brain and temporal lobe structuresTed K Yanagihara, J Ricardo McFaline-Figueroa, Nicholas J Giacalone, et al.Neuro-Oncology|January 8, 2019
Preclinical assessment of MEK1/2 inhibitors for neurofibromatosis type 2-associated schwannomas reveals differences in efficacy and drug resistance developmentMarisa A Fuse, Christine T Dinh, Jeremie Vitte, et al.Neuro-Oncology|January 17, 2019
Malignant primary brain and other central nervous system tumors diagnosed in Canada from 2009 to 2013Emily V Walker, Faith G Davis, Neuro-Oncology|January 17, 2019
Imaging and diagnostic advances for intracranial meningiomasRaymond Y Huang, Wenya Linda Bi, Brent Griffith, et al.Neuro-Oncology|February 7, 2019
Septal dysembryoplastic neuroepithelial tumor: a comprehensive clinical, imaging, histopathologic, and molecular analysisJason C H Chiang, Julie H Harreld, Ryuma Tanaka, et al.Neuro-Oncology|March 18, 2020
Crosstalk between GBM cells and mesenchymal stemlike cells promotes the invasiveness of GBM through the C5a/p38/ZEB1 axisEun-Jung Lim, Seungmo Kim, Yoonjee Oh, et al.Neuro-Oncology|March 14, 2020
MGMT promoter methylation level in newly diagnosed low-grade glioma is a predictor of hypermutation at recurrenceRadhika Mathur, Yalan Zhang, Matthew R Grimmer, et al.Neuro-Oncology|January 18, 2020
Neurologic and oncologic features of Erdheim-Chester disease: a 30-patient seriesAnkush Bhatia, Vaios Hatzoglou, Gary Ulaner, et al.Neuro-Oncology|March 28, 2020
Evaluation of RAPNO criteria in medulloblastoma and other leptomeningeal seeding tumors using MRI and clinical dataJian Peng, Hao Zhou, Oliver Tang, et al.Pageof 315